You are here

Clinical Trials: Trauma

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, July 7, 2021 - 12:00
Condition:   Acute Lung Injury
Intervention:   Biological: human derived umbilical cord derived mesenchymal stem cells
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting
Posted: Monday, June 14, 2021 - 12:00
Condition:   Plastic Surgeries
Interventions:   Biological: BLOOD SAMPLES;   Biological: surgical tissue samples
Sponsor:   Assistance Publique Hopitaux De Marseille
Recruiting
Posted: Friday, June 11, 2021 - 12:00
Condition:   Covid19
Interventions:   Drug: ALLOCETRA-OTS;   Other: Placebo
Sponsor:   Enlivex Therapeutics Ltd.
Not yet recruiting
Posted: Wednesday, June 2, 2021 - 12:00
Conditions:   Acute Respiratory Distress Syndrome;   Ards
Interventions:   Biological: COVI-MSC;   Drug: Placebo
Sponsor:   Sorrento Therapeutics, Inc.
Not yet recruiting
Posted: Tuesday, May 18, 2021 - 12:00
Conditions:   Burns;   Burns Second Degree;   Burns Deep Second Degree
Intervention:   Device: CellMist™ System
Sponsor:   RenovaCare, Inc
Not yet recruiting
Posted: Monday, May 17, 2021 - 12:00
Conditions:   Adypose Mesenchimal Stem Cell;   Ligament Rupture;   Ligament Derived Conditined Medium
Intervention:   Biological: adypose mesenchymal conditioned medium and ligament derived conditioned medium
Sponsor:   Gadjah Mada University
Recruiting
Posted: Wednesday, May 12, 2021 - 12:00
Condition:   Androgenetic Alopecia
Intervention:   Device: Fractionated Thulium laser
Sponsor:   Montefiore Medical Center
Not yet recruiting
Posted: Monday, April 19, 2021 - 12:00
Conditions:   Chronic Low Back Pain;   Degenerative Disc Disease
Intervention:   Biological: Platelet rich plasma (PRP) with exosomes
Sponsor:   Dr. Himanshu Bansal Foundation
Recruiting
Posted: Friday, April 9, 2021 - 12:00
Condition:   Amputation
Intervention:   Combination Product: Autologous Volar Fibroblast Injection into the Terminal Limb of Amputees
Sponsors:   Major Extremity Trauma Research Consortium;   United States Department of Defense
Not yet recruiting
Posted: Tuesday, March 23, 2021 - 12:00
Conditions:   Spinal Cord Injury, Acute;   Spinal Cord Injury at C4 Level With Complete Lesion;   Spinal Cord Injury at C5-C7 Level With Complete Lesion
Intervention:   Biological: Neural precursor cells derived from human embryonic stem cell line
Sponsors:   S.Biomedics Co., Ltd.;   Linical Co., Ltd.;   Yonsei University
Not yet recruiting

Pages